Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Samonigg

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Cancer|December 1, 1995
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapyH Ludwig, E Sundal, M Pecherstorfer, et al.
Cancer|March 15, 1996
Sequential treatment of recurrent mesenteric desmoid tumorT Bauernhofer, H Stöger, M Schmid, et al.
British Journal of Cancer|December 21, 2013
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancerM Stotz, M Pichler, G Absenger, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancerH Samonigg, H Stöger, A K Kasparek, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig heartsG Stark, U Stark, H Samonigg, et al.
Lancet (London, England)|January 20, 1990
Immunoreactivity of patient with colorectal cancer metastasis after immunisation with anti-idiotypesH Loibner, R Plot, A Rot, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Onkologie|October 1, 1989
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Investigational New Drugs|May 1, 1990
Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II studyW Scheithauer, H Samonigg, D Depisch, et al.
Zeitschrift Fur Kardiologie|March 1, 1994
[Toxoplasmosis peri-myocarditis as initial manifestation of highly malignant non-Hodgkin's lymphoma]R Zweiker, B Eber, H Samonigg, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Cancer|December 1, 1995
Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapyH Ludwig, E Sundal, M Pecherstorfer, et al.
Cancer|March 15, 1996
Sequential treatment of recurrent mesenteric desmoid tumorT Bauernhofer, H Stöger, M Schmid, et al.
British Journal of Cancer|December 21, 2013
The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancerM Stotz, M Pichler, G Absenger, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1991
Prednimustine combined with mitoxantrone and 5-fluorouracil for first and second-line chemotherapy in advanced breast cancerH Samonigg, H Stöger, A K Kasparek, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1990
Comparison of acute effects of anthracyclines on cardiac electrophysiological parameters of isolated guinea-pig heartsG Stark, U Stark, H Samonigg, et al.
Lancet (London, England)|January 20, 1990
Immunoreactivity of patient with colorectal cancer metastasis after immunisation with anti-idiotypesH Loibner, R Plot, A Rot, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Onkologie|October 1, 1989
Vindesine-epirubicin versus vindesine-mitoxantrone in metastatic breast cancerH Hausmaninger, M Lehnert, G Steger, et al.
Investigational New Drugs|May 1, 1990
Pirarubicin (4'-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer. A Clinical Phase II studyW Scheithauer, H Samonigg, D Depisch, et al.
Zeitschrift Fur Kardiologie|March 1, 1994
[Toxoplasmosis peri-myocarditis as initial manifestation of highly malignant non-Hodgkin's lymphoma]R Zweiker, B Eber, H Samonigg, et al.
Pageof 8